The Royal's Institute of Mental Health Research clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21
What changed in the last 30 days
3 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 2 with minor changes only.
- Minor: Enhancing the Effect of Stellate Ganglion Block · PTSD: Bupivacaine vs Bupivacaine + Ketamine Interventions modified
- Notable: Behavioural Activation Therapy and Ketamine for Treatment-Resistant Depression Recruitment opened
- Minor: Understanding and Treating Suicidal Ideation With Ketamine Primary and study completion pushed from Oct 2026 to Mar 2027
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-09 | NCT07927036 Enhancing the Effect of Stellate Ganglion Block in the Treatment of PTSD: Bupivacaine vs… | Phase 2 | Not Yet Recruiting |
Active trials by phase
| Phase 2 | 1 | |
| Phase 2/3 | 2 | |
| Phase 3 | 1 | |
| Phase 4 | 1 |
Disease areas by active trials
Depression (2) · PTSD (2) · Obesity (1)
Get alerts when The Royal's Institute of Mental Health Research's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.